Oxycodone Hydrochloride Lucis Pharma

Active Ingredient:: Oxycodone Hydrochloride
Origin:: EU

Oxycodone Hydrochloride Lucis Pharma (Oxycodone Hydrochloride)

International sale not permitted. Listed for the domestic market and B2B only.

Oxycodone, the active ingredient in Oxycodone Hydrochloride Lucis Pharma, is an opioid analgesic presented as an oral formulation for oral use. It is indicated for the management of moderate to severe pain in adult patients.
GNH India supplies Oxycodone Hydrochloride Lucis Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Lucis Pharma Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxycodone is an opioid analgesic used to manage pain that involves the central nervous system.

Moderate to severe acute pain: provides relief by reducing the perception of pain.
Post‑operative pain: helps control pain after surgical procedures.
Cancer‑related pain: alleviates persistent severe pain associated with malignancy.

How It Works

Oxycodone acts as a full agonist at the mu‑opioid receptors in the central nervous system. Binding to these receptors inhibits the release of neurotransmitters involved in pain transmission, leading to decreased neuronal excitability and altered perception of painful stimuli. The drug also modulates descending pain pathways, contributing to its analgesic effect.

Side Effects

Common side effects are often related to central nervous system and gastrointestinal effects.

Common Side Effects

Nausea: mild to moderate upset stomach.
Constipation: reduced bowel motility.
Dizziness: sensation of light‑headedness.
Drowsiness: increased sleepiness.
Dry mouth: reduced salivation.
Sweating: excessive perspiration.

Serious or Rare Side Effects

Respiratory depression: slowed or shallow breathing.
Severe hypotension: marked drop in blood pressure.
Seizures: occasional convulsive episodes.
Adrenal insufficiency: impaired cortisol response.
Dependence or addiction: potential for misuse.
Anaphylaxis: rare severe allergic reaction.

Precautions & Warnings

Before initiating therapy, several safety considerations should be addressed.

Assess pain severity: confirm that opioid treatment is appropriate for the level of pain.
Evaluate respiratory function: monitor for signs of respiratory depression, especially in high‑risk patients.
Review substance‑use history: exercise caution in individuals with prior opioid or alcohol dependence.
Avoid concurrent CNS depressants: limit use of benzodiazepines, alcohol, or other sedatives.
Pregnancy and lactation: discuss potential risks with the prescriber; use only if benefits outweigh risks.
Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Oxycodone may interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid)

Benzodiazepines: additive central nervous system depression.
Alcohol: increased sedation and risk of respiratory depression.
Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise oxycodone plasma concentrations.

Moderate Interactions (Monitor Closely)

CYP2D6 inhibitors (e.g., fluoxetine): can affect oxycodone metabolism.
Anticholinergic agents: may exacerbate constipation.

Frequently Asked Questions

Oxycodone Hydrochloride Lucis Pharma is an opioid analgesic prescribed to relieve moderate to severe pain, such as acute postoperative pain, cancer‑related pain, or severe acute injuries, when non‑opioid therapies are insufficient.

Oxycodone binds to mu‑opioid receptors in the brain and spinal cord, inhibiting the release of neurotransmitters that transmit pain signals. This reduces neuronal excitability and alters the perception of pain, providing analgesia.

The appropriate dose of oxycodone is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, age, weight, and overall health. Dosage regimens are individualized and must follow local prescribing guidelines.

Oxycodone is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out. It should be used during pregnancy only if the potential benefit justifies the potential risk. Breastfeeding mothers should consult their healthcare provider, as the drug can pass into breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Oxycodone is a strong mu‑opioid receptor agonist with a potency comparable to morphine but often considered more effective for certain types of severe pain. Compared with weaker opioids like codeine, oxycodone provides more reliable analgesia but also carries a higher risk of respiratory depression and dependence.

Store Oxycodone Hydrochloride Lucis Pharma at ambient temperature, below 25 °C, in the original packaging. Protect it from moisture, direct sunlight, and excessive heat to maintain product stability.

Oxycodone is administered orally, typically as a tablet or capsule, and should be taken exactly as prescribed. Swallow the dosage whole with water; do not crush or chew unless specifically instructed by a healthcare professional.

The most serious risks include respiratory depression, severe hypotension, potential for dependence or addiction, and rare but life‑threatening allergic reactions such as anaphylaxis. Patients should be monitored closely, especially during initiation or dose escalation.

Oxycodone should be avoided in individuals with known hypersensitivity to the drug, severe respiratory insufficiency, acute or severe asthma, paralytic ileus, or a history of significant opioid misuse. It is also contraindicated when used concurrently with certain CNS depressants without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 10 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.